How Media Coverage of Oral Minoxidil for Hair Loss Has Impacted Prescribing Habits

The publication of a New York Times article in August 2022 significantly influenced the prescribing habits of dermatologists regarding low-dose oral minoxidil (LDOM) for hair loss. A survey of 65 US-based board-certified dermatologists revealed that 42% began prescribing or increased their use of LDOM following the article. Data from Epiphany Dermatology and Summit Pharmacy showed substantial increases in LDOM prescriptions post-publication, with Epiphany Dermatology reporting 1,377 prescriptions in the 8 months following the article. Studies have shown LDOM to be a safe and effective treatment for alopecia, with minimal adverse effects. This highlights the powerful impact media coverage can have on medical practices and patient inquiries.